Personalized Neoantigen Cancer Vaccine for Patients With Solid Tumors
NCT06614140
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
8
Enrollment
INDUSTRY
Sponsor class
Conditions
Cancer
Solid Tumor, Adult
Interventions
BIOLOGICAL:
Personalized Neoantigen Peptide Vaccine with Poly-ICLC and Checkpoint Inhibitors
Sponsor
Seqker Biosciences, Inc.